Cargando…
Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
PURPOSE: To predict visual acuity (VA) 1 month after anti-vascular endothelial growth factor (VEGF) therapy in patients with diabetic macular edema (DME) by using machine learning. METHODS: This retrospective study included 281 eyes with DME receiving intravitreal anti-VEGF treatment from January 1,...
Autores principales: | Zhang, Ying, Xu, Fabao, Lin, Zhenzhe, Wang, Jiawei, Huang, Chao, Wei, Min, Zhai, Weibin, Li, Jianqiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042629/ https://www.ncbi.nlm.nih.gov/pubmed/35493607 http://dx.doi.org/10.1155/2022/5779210 |
Ejemplares similares
-
Relationship Between Macular Thickness and Visual Acuity in the
Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic
Review
por: Wang, Patrick, et al.
Publicado: (2022) -
Prediction of the Short-Term Therapeutic Effect of Anti-VEGF Therapy for Diabetic Macular Edema Using a Generative Adversarial Network with OCT Images
por: Xu, Fabao, et al.
Publicado: (2022) -
Flavoprotein Fluorescence Correlation with Visual Acuity Response in Patients Receiving Anti-VEGF Injection for Diabetic Macular Edema
por: Andrade Romo, Jorge S., et al.
Publicado: (2018) -
Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy
por: Eraslan, Seher, et al.
Publicado: (2020) -
Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)